Meridian Bioscience Inc. (VIVO)
(Delayed Data from NSDQ)
$11.51 USD
-0.48 (-4.00%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.50 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.51 USD
-0.48 (-4.00%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.50 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
The Zacks Analyst Blog Highlights: Ryerson Holding, Schnitzer Steel, Scholastic, P.A.M. Transportation Services and Meridian Bioscience
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ryerson Holding, Schnitzer Steel, Scholastic, P.A.M. Transportation Services and Meridian Bioscience
Zacks.com featured highlights include: Bonanza Creek Energy, Meridian Bioscience, Ameris and Lakeland Industries
by Zacks Equity Research
Zacks.com featured highlights include: Bonanza Creek Energy, Meridian Bioscience, Ameris and Lakeland Industries
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations
Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech
by Zacks Equity Research
Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech
4 Stocks With High Net Income Ratio to Scoop Up
by Nitish Marwah
Investors always look for companies with a high level of profitability regardless of the ongoing market condition.
5 Top-Ranked Small Hidden Gems With Strong Upside in 2021
by Nalak Das
We have narrowed down our search to five small cap stocks that have strong growth potential for 2021. These are: SCHL, SCHN, RYI, PTSI, VIVO.
Bet on Rising P/E With These 5 Top-Ranked Stocks
by Sanghamitra Saha
Want to try some out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Can Meridian Bioscience (VIVO) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Meridian Bioscience (VIVO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is Meridian Bioscience (VIVO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (VIVO) Outperforming Other Medical Stocks This Year?
Top Stock Picks for Week of December 28, 2020
by Panel Of Zacks Experts
Two Stocks With an Upward Moving Earnings Outlook.
Zacks.com featured highlights include: LAKE, VNW, VIVO, CSV and WYY
by Zacks Equity Research
Zacks.com featured highlights include: LAKE, VNW, VIVO, CSV and WYY
6 Top-Rated Stocks With Solid Net Profit Margin
by Anirudha Bhagat
Here are six best-performing stocks with substantial net profit margins that can contribute toward making an enriching portfolio.
Zacks.com featured highlights include: Meridian Bioscience, Piper Sandler, Herc Holdings, Aviat Networks and Carriage Services
by Zacks Equity Research
Zacks.com featured highlights include: Meridian Bioscience, Piper Sandler, Herc Holdings, Aviat Networks and Carriage Services
6 Top-Rated Stocks to Bet On With Solid Net Profit Margins
by Anirudha Bhagat
Let's take a look at these six top-ranked stocks with impressive net profit margins for a winning portfolio.
Is Meridian Bioscience (VIVO) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (VIVO) Outperforming Other Medical Stocks This Year?
Why Meridian Bioscience (VIVO) Might be Well Poised for a Surge
by Zacks Equity Research
Meridian Bioscience (VIVO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power
by Zacks Equity Research
Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power
Sail Through the Choppy Market With These 5 Low-Beta Stocks
by Nilanjan Banerjee
To combat the choppy market conditions, it is of utmost importance to create a portfolio of low-beta stocks.
New Strong Buy Stocks For November 18th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (VIVO) Outperforming Other Medical Stocks This Year?
Meridian Bioscience (VIVO) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 35.71% and 7.88%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Meridian Bioscience (VIVO) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Owens & Minor (OMI) Catches Eye: Stock Jumps 8.3%
by Zacks Equity Research
Owens & Minor (OMI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Meridian Bioscience (VIVO) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 129.17% and 28.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Meridian Bioscience's (VIVO) Q3 Earnings?
by Trina Mukherjee
Meridian Bioscience's (VIVO) fiscal third-quarter results are likely to reflect strong performance by Life Science business line.